Neil Bander,Joseph Osborne,Stanley Goldsmith,Shankar Vallabhajosula
申请号：
US16653655
公开号：
US20200282085A1
申请日:
2019.10.15
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A method for identifying a patient for cancer therapy can include administering a diagnostic dose of a detectably labeled first binding agent to a patient, the detectably labeled binding agent being capable of binding a molecular target. The method also includes selecting a patient for administration of a therapeutic dose of a second binding agent capable of binding a cellular target, wherein the selected patient exhibits a positive reading for the detectably labeled first binding agent. Furthermore, the method can include administering a therapeutic dose of the second binding agent to the patient.
